You have 9 free searches left this month | for more free features.

City

Chengdu (1)

Shanghai (1)

Condition

Lymphoblastic Lymphoma (1)

Overall Status

Active, not recruiting (1)

Phase

phase 3 (1)

Sponsor

Children's Cancer Group, China (1)

Collaborator

Children's Hospital Of Soochow University (1)

Nanjing Children's Hospital (1)

Qilu Hospital of Shandong University (1)

Shanghai Children's Medical Center (1)

Tianjin Medical University Cancer Institute and Hospital (1)

Tongji Hospital (1)

West China Second University Hospital (1)

Xiangya Hospital of Central South University (1)

Intervention

6-mercaptopurine,methotrexate (1)

dexamethasone, cytarabine, etoposide, pegylated-asparaginase (1)

dexamethasone, vindesine, methotrexate, ifosfamide, daunorubicin, pegylated-asparaginase (1)

dexamethasone,vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, doxorubicin, 6-mercaptopurine (1)

dexamethasone,vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, methotrexate (1)

methotrexate, 6-mercaptopurine (1)

prednisone,vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, daunorubicin, 6-mercaptopurine (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

6-mercaptopurine,methotrexate

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoblastic Lymphoma Trial in Chengdu, Shanghai (Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide,

Active, not recruiting

Lymphoblastic Lymphoma

Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
+6 more

Chengdu, China
+1 more

Mar 17, 2022